Physician profile
Philip T Ramsay
NPI 1396866869
$7,342.41
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,130 · 2020: $486 · 2021: $1,038 · 2022: $1,178 · 2023: $1,417 · 2024: $92.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Food and Beverage: $510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Food and Beverage | $510.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,722.95 | 2019-2024 | Da Vinci Sp, Da Vinci Surgical System |
| Medtronic, INC. | $819.62 | 2021-2022 | |
| Kerecis Limited | $318.99 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $301.77 | 2021-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Becton, Dickinson and Company | $199.34 | 2022 | |
| Stryker Corporation | $168.97 | 2021 | |
| Tela Bio, INC. | $128.41 | 2019 | |
| Conmed Corporation | $127.45 | 2020 | |
| La Jolla Pharmaceutical Company | $122.32 | 2020 | |
| Heron Therapeutics, INC. | $118.76 | 2022 | |
| Baxter Healthcare | $116.63 | 2022 | |
| Depuy Synthes Sales INC. | $87.91 | 2021 | |
| Aroa Biosurgery Incorporated | $67.13 | 2022 | |
| Davol INC. | $22.52 | 2021 | |
| Solventum Corporation | $19.64 | 2024 | V.A.C. Veraflo Cleanse Choice |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Ramsay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.